Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderately Active Ulcerative Colitis”

271 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 271 results

Post-approval studies (Phase 4)Study completedNCT01408810
What this trial is testing

Evaluation of Histologic and Endoscopic Remission Induced by Infliximab in Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Grupo de Estudo da Doença Inflamatória Intestinal 21
Large-scale testing (Phase 3)Active Not RecruitingNCT04033445
What this trial is testing

Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Janssen Research & Development, LLC 1,064
Testing effectiveness (Phase 2)Study completedNCT02493712
What this trial is testing

A Phase 2a, Multicenter, Randomized, Double-blind, Parallel Group, Placebo-controlled Trial of IBD98-M

Who this might be right for
Colitis, Ulcerative
Holy Stone Healthcare Co., Ltd 51
Early research (Phase 1)Ended earlyNCT03169894
What this trial is testing

Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis

Who this might be right for
Crohn DiseaseUlcerative Colitis
Avalo Therapeutics, Inc. 8
Not applicableStudy completedNCT02922881
What this trial is testing

Microbiota-targeted Diet for Pediatric UC

Who this might be right for
Ulcerative Colitis
Children's Hospital of Philadelphia 5
Testing effectiveness (Phase 2)Ended earlyNCT04677179
What this trial is testing

LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Colitis, Ulcerative
Nektar Therapeutics 81
Testing effectiveness (Phase 2)Study completedNCT00572585
What this trial is testing

Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Novartis Pharmaceuticals 60
Post-approval studies (Phase 4)WithdrawnNCT02760615
What this trial is testing

Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study

Who this might be right for
Colitis, UlcerativeCrohn Disease
Takeda
Early research (Phase 1)Ended earlyNCT06681389
What this trial is testing

NP-201 Acetate Injection in Healthy Adult Volunteers and in Patients With Mild-To-Moderate Active Ulcerative Colitis

Who this might be right for
Healthy Adult VolunteersActive Ulcerative ColitisActive Ulcerative Colitis (UC)
NIBEC Co., Ltd. 35
Early research (Phase 1)Study completedNCT01900574
What this trial is testing

Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 35
Large-scale testing (Phase 3)Looking for participantsNCT06865417
What this trial is testing

A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Alfasigma S.p.A. 80
Large-scale testing (Phase 3)Ended earlyNCT01805791
What this trial is testing

A Phase III Trial of HMPL-004 in Patients With Mild to Moderate Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Hutchison Medipharma Limited 201
Large-scale testing (Phase 3)Study completedNCT02165215
What this trial is testing

The Efficacy and Safety of Etrolizumab Treatment in Maintenance of Disease Remission in Ulcerative Colitis (UC) Participants Who Are Naive to Tumor Necrosis Factor (TNF) Inhibitors

Who this might be right for
Colitis, Ulcerative
Hoffmann-La Roche 359
Not applicableNot Yet RecruitingNCT07062185
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of ENC1018 Capsules in Patients With Moderate-to-severe Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis (UC)
Tang-Du Hospital 10
Large-scale testing (Phase 3)UnknownNCT03716388
What this trial is testing

Fecal Microbiota Therapy Vs 5-aminosalicylates for Induction of Remission in Newly Diagnosed Mild-moderately Active UC

Who this might be right for
Ulcerative Colitis Chronic MildUlcerative Colitis Chronic Moderate
Dayanand Medical College and Hospital 20
Testing effectiveness (Phase 2)Study completedNCT02888379
What this trial is testing

Phase 2a Study to Evaluate the Safety/Tolerability and Efficacy of TOP1288 200 mg Rectal Solution Once Daily for 4 Weeks in Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Topivert Pharma Ltd 77
Large-scale testing (Phase 3)UnknownNCT04176588
What this trial is testing

Etrasimod in Subjects With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Moderately to Severely Active Ulcerative Colitis
Everstar Therapeutics Limited 341
Testing effectiveness (Phase 2)Study completedNCT02337608
What this trial is testing

Efficacy and Safety of GLPG1205 in Subjects With Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Lakefront Biotherapeutics NV 64
Post-approval studies (Phase 4)Looking for participantsNCT06581328
What this trial is testing

Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting

Who this might be right for
Ulcerative ColitisCrohn's Disease
Takeda 200
Large-scale testing (Phase 3)Study completedNCT02819635
What this trial is testing

Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis (UC)
AbbVie 1,302
Next Page